Antimicrobial resistance patterns of urinary tract infection organisms isolated from pregnant women’s urinary samples at lancet clinical laboratories in Zimbabwe, 2021
Abstract
Worldwide, bacterial infections are a main cause of morbidity and mortality, mainly in low-income countries. The world emergence of antimicrobial resistance negatively impact the management of infectious diseases. Nationwide, there is an increasing concern over antimicrobial resistance (AMR) recently evaluated to contribute for more than 700,000 deaths per year across the globe. The key objective of this present study is to characterise the antimicrobial resistance patterns of urinary tract organisms isolated from pregnant women’s urinary samples analysed at Lancet Clinical Laboratories in Zimbabwe from January to December 2021. This was a laboratory based, cross sectional study conducted among pregnant women’s samples analysed at the laboratory. Microbiology results logbook and patients’ clinical data were used to evaluate basic descriptive statistics (proportions and mean) of participants engaged in this study. We describe the characteristics of variables of respondents where categorical variables were portrayed in the form of numbers and percentages in table, figures format. The prevalence of UTI was 60% with the main isolated bacteria being Escherichia coli (28.10%), Staphylococcus aureus (9.18%) and Kleibseilla pneumoniae (10.27%). There was association between gestational ages with UTI. The prevalence of AMR was 54%. The highest resistant drugs being Ampicillin (60%), Vancomycin (45%) and Penicillin (40%), the least resistant were chloramphenicol (15%), ciprofloxacin…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.